WNT9A and colorectal carcinoma: The substantial and consistent upregulation of Wnt9A gene expression in LiCl-treated CRC cells (ranging from 7- to 48-fold across 5 short term lines) that we observed in association with proliferation inhibition (ranging from 58% to 98%), coupled with the literature cited here, justified investigating the contribution of Wnt9A in these effects.